Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults

NCT02915913 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-10-11

No results posted yet for this study

Summary

The BrainFit Study aims to examine acute effects of High Intensity Interval- vs Resistance or Combined program has benefits on Cognitive Function as well as on secretion and regulation of neurotrophic factors or neurotrophins in a cohort of sedentary, overweight adults (aged 18-30 years) from Bogota, Colombia.

Conditions

  • Cognitive Function
  • Motor Activity
  • Obesity

Interventions

BEHAVIORAL

Experimental: High Intensity Interval

Walking on a treadmill 4min at 80-90% peak heart rate and recovery 4 min at 65% peak heart rate until expenditure of 500 kcal

BEHAVIORAL

Resistance training

Completing a resistance circuit (including upper and lower muscle groups) as many times as needed according to subject weight until expenditure of 500 kcal

BEHAVIORAL

Plus: High Intensity Interval + Resistance Training

Walking on a treadmill as intervention 1 until 50% the energy expenditure prescribed is reached, then completing a resistance circuit until 100% energy expenditure is reached

OTHER

Non-exercise

This group will receive the usual clinical care according to the consensus recommendations of the national goals for cardiovascular health promotion and disease reduction of the American Heart Association and Colombian guidelines COLDEPORTES.

Sponsors & Collaborators

  • Universidad del Rosario

    collaborator OTHER
  • Universidad Nacional de Colombia

    collaborator OTHER
  • Universidad Santo Tomas

    lead OTHER

Principal Investigators

  • Robinson Ramírez-Vélez, Ph.D · Universidad del Rosario

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Colombia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02915913 on ClinicalTrials.gov